1. Moreno, T., Dyer, P. & Tallon, S. (2020). Cannabinoid Decarboxylation: A Comparative Kinetic Study. Industrial & Engerineering Chemistry Research, 59(46).
3. Müller-Vahl, K. & Grotenhemen, F. (2017, Februrary 24). Medizinisches Cannabis. Die wichtigsten Änderungen. Deutsches Ärzteblatt, 114(8), 352-356.
5. Kalant, H. (2001). Medicinal Use of Cannabis: History and Current Status. Pain Research and Management, vol. 6.
7. Skelley, J. W. et al. (2020). Use of cannabidiol in anxiety and anxiety-related disorders. Journal of the American Pharmacists Association, 60(1), 253-261
9. Moltke, J. & Hondocha, C. (2021). Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety and sleep problems. Journal of Cannabis Research, 3(5).
11. Stith, S. et al. (2022). The Effectiveness of Common Cannabis Products for Treatment of Nausea. Journal of Clinical Gastroenterology, 56(4), 331-338.
13. Lee, J. (2023). Tetrahydrocannabinol and Dopamine D1 Receptor. ChemRxiv. Cambridge Open Engage.
15. Elzinga, S., Raber, J., Fischerdick, J. T. (2015). Cannabinoids and Terpenes as Chemotaxonomic Markers in Cannabis. Natural Products Chemistry & Research, 3(4).